Losing weight for a better health: Role for the gut microbiota

Clinical Nutrition Experimental

Volumn 6, Issue , 2016, Pages 39-58

  Dao, Maria Carlota ^a,b,c   Everard, Amandine ^d   Clément, Karine ^a,b,c   Cani, Patrice D ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Equipe Nutriomique: Nutrition et Obésité Approches Systémiques   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Gastric bypass; Gut microbiota; Obesity; Prebiotics; Probiotics; Weight loss

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; BARIATRIC SURGERY; CALORIC RESTRICTION; CLINICAL PRACTICE; DATA ANALYSIS; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; HEALTH IMPACT ASSESSMENT; HEALTH STATUS; HUMAN; INTESTINE FLORA; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PREDICTION; PROCESS OPTIMIZATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 84962815816     PISSN: 23529393     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yclnex.2015.12.001     Document Type: Article

References (80)

1. Clarke S.F., Murphy E.F., Nilaweera K., Ross P.R., Shanahan F., O'Toole P.W., et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012, 3:186-202. 10.4161/gmic.20168.
2. Hansen T.H., Gøbel R.J., Hansen T., Pedersen O. The gut microbiome in cardio-metabolic health. Genome Med 2015, 7. 10.1186/s13073-015-0157-z.
3. Tremaroli V., Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249. 10.1038/nature11552.
4. Delzenne N.M., Cani P.D., Everard A., Neyrinck A.M., Bindels L.B. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia 2015, 58:2206-2217. 10.1007/s00125-015-3712-7.
5. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718-15723. 10.1073/pnas.0407076101.
6. Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007, 104:979-984. 10.1073/pnas.0605374104.
7. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031. 10.1038/nature05414.
8. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772. 10.2337/db06-1491.
9. Vila I.K., Badin P.-M., Marques M.-A., Monbrun L., Lefort C., Mir L., et al. Immune cell toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis. Cell Rep 2014, 7:1116-1129. 10.1016/j.celrep.2014.03.062.
10. Everard A., Geurts L., Caesar R., Van Hul M., Matamoros S., Duparc T., et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun 2014, 5:5648. 10.1038/ncomms6648.
11. Org E., Parks B.W., Joo J.W.J., Emert B., Schwartzman W., Kang E.Y., et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res 2015, 25:1558-1569. 10.1101/gr.194118.115.
12. Zhang C., Li S., Yang L., Huang P., Li W., Wang S., et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun 2013, 4. 10.1038/ncomms3163.
13. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180. 10.1038/nature09944.
14. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.-Y., Keilbaugh S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108. 10.1126/science.1208344.
15. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546. 10.1038/nature12506.
16. Furet J.-P., Kong L.-C., Tap J., Poitou C., Basdevant A., Bouillot J.-L., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59:3049-3057. 10.2337/db10-0253.
17. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102:11070-11075. 10.1073/pnas.0504978102.
18. Munukka E., Wiklund P., Pekkala S., Völgyi E., Xu L., Cheng S., et al. Women with and without metabolic disorder differ in their gut microbiota composition. Obes Silver Spring Md 2012, 20:1082-1087. 10.1038/oby.2012.8.
19. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484. 10.1038/nature07540.
20. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obes Silver Spring Md 2010, 18:190-195. 10.1038/oby.2009.167.
21. Cotillard A., Kennedy S.P., Kong L.C., Prifti E., Pons N., Le Chatelier E., et al. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588. 10.1038/nature12480.
22. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.-J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105:16731-16736. 10.1073/pnas.0804812105.
23. Munukka E., Pekkala S., Wiklund P., Rasool O., Borra R., Kong L., et al. Gut-adipose tissue axis in hepatic fat accumulation in humans. J Hepatol 2014, 61:132-138. 10.1016/j.jhep.2014.02.020.
24. Zhang X., Shen D., Fang Z., Jie Z., Qiu X., Zhang C., et al. Human gut microbiota changes reveal the progression of glucose intolerance. PloS One 2013, 8. e71108. 10.1371/journal.pone.0071108.
25. Dao M.C., Everard A., Aron-Wisnewsky J., Sokolovska N., Prifti E., Verger E.O., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 2015, 10.1136/gutjnl-2014-308778.
26. Kong L.C., Wuillemin P.-H., Bastard J.-P., Sokolovska N., Gougis S., Fellahi S., et al. Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. Am J Clin Nutr 2013, 98:1385-1394. 10.3945/ajcn.113.058099.
27. Kong L.C., Holmes B.A., Cotillard A., Habi-Rachedi F., Brazeilles R., Gougis S., et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PloS One 2014, 9:e109434. 10.1371/journal.pone.0109434.
28. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007, 73:1073-1078. 10.1128/AEM.02340-06.
29. Russell W.R., Gratz S.W., Duncan S.H., Holtrop G., Ince J., Scobbie L., et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 2011, 93:1062-1072. 10.3945/ajcn.110.002188.
30. Brinkworth G.D., Noakes M., Clifton P.M., Bird A.R. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 2009, 101:1493-1502. 10.1017/S0007114508094658.
31. Nadal I., Santacruz A., Marcos A., Warnberg J., Garagorri J.M., Garagorri M., et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes 2005, 2009(33):758-767. 10.1038/ijo.2008.260.
32. Santacruz A., Marcos A., Wärnberg J., Martí A., Martin-Matillas M., Campoy C., et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obes Silver Spring Md 2009, 17:1906-1915. 10.1038/oby.2009.112.
33. Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 2013, 7:880-884. 10.1038/ismej.2012.153.
34. Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341:1241214. 10.1126/science.1241214.
35. Bindels L.B., Delzenne N.M., Cani P.D., Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015, 12:303-310. 10.1038/nrgastro.2015.47.
36. Cani P.D., Dewever C., Delzenne N.M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 2004, 92:521-526.
37. Delzenne N.M., Cani P.D., Daubioul C., Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 2005, 93(Suppl. 1):S157-S161.
38. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383. 10.1007/s00125-007-0791-0.
39. Everard A., Lazarevic V., Gaïa N., Johansson M., Ståhlman M., Backhed F., et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 2014, 8:2116-2130. 10.1038/ismej.2014.45.
40. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013, 110:9066-9071. 10.1073/pnas.1219451110.
41. Anhê F.F., Roy D., Pilon G., Dudonné S., Matamoros S., Varin T.V., et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015, 64:872-883. 10.1136/gutjnl-2014-307142.
42. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., et al. Expert consensus document. The International Scientific Association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014, 11:506-514. 10.1038/nrgastro.2014.66.
43. Cani P.D., Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 2015, 32:21-27. 10.1016/j.copbio.2014.10.006.
44. Park S., Bae J.-H. Probiotics for weight loss: a systematic review and meta-analysis. Nutr Res 2015, 35:566-575. 10.1016/j.nutres.2015.05.008.
45. Yun S.I., Park H.O., Kang J.H. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009, 107:1681-1686. 10.1111/j.1365-2672.2009.04350.x.
46. Takemura N., Okubo T., Sonoyama K. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med Maywood NJ 2010, 235:849-856. 10.1258/ebm.2010.009377.
47. Arora T., Anastasovska J., Gibson G., Tuohy K., Sharma R.K., Bell J., et al. Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet-induced obese mice. Br J Nutr 2012, 108:1382-1389. 10.1017/S0007114511006957.
48. Naito E., Yoshida Y., Makino K., Kounoshi Y., Kunihiro S., Takahashi R., et al. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 2011, 110:650-657. 10.1111/j.1365-2672.2010.04922.x.
49. Moya-Pérez A., Neef A., Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PloS One 2015, 10:e0126976. 10.1371/journal.pone.0126976.
50. Chen J.J., Wang R., Li X., Wang R. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med Maywood NJ 2011, 236:823-831. 10.1258/ebm.2011.010399.
51. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermúdez-Humarán L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011, 3:559-572. 10.1002/emmm.201100159.
52. Cani P.D., Lecourt E., Dewulf E.M., Sohet F.M., Pachikian B.D., Naslain D., et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009, 90:1236-1243. 10.3945/ajcn.2009.28095.
53. Pedersen C., Lefevre S., Peters V., Patterson M., Ghatei M.A., Morgan L.M., et al. Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study. Appetite 2013, 66:44-53. 10.1016/j.appet.2013.02.017.
54. Bonsu N.K.A., Johnson C.S., McLeod K.M. Can dietary fructans lower serum glucose?. J Diabetes 2011, 3:58-66. 10.1111/j.1753-0407.2010.00099.x.
55. Dewulf E.M., Cani P.D., Claus S.P., Fuentes S., Puylaert P.G.B., Neyrinck A.M., et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013, 62:1112-1121. 10.1136/gutjnl-2012-303304.
56. Malaguarnera M., Vacante M., Antic T., Giordano M., Chisari G., Acquaviva R., et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 2012, 57:545-553. 10.1007/s10620-011-1887-4.
57. Druart C., Alligier M., Salazar N., Neyrinck A.M., Delzenne N.M. Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Adv Nutr Bethesda Md 2014, 5:624S-633S. 10.3945/an.114.005835.
58. Still C.D., Wood G.C., Chu X., Manney C., Strodel W., Petrick A., et al. Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obes Silver Spring Md 2014, 22:888-894. 10.1002/oby.20529.
59. Aron-Wisnewsky J., Julia Z., Poitou C., Bouillot J.-L., Basdevant A., Chapman M.J., et al. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab 2011, 96:1151-1159. 10.1210/jc.2010-2378.
60. Dixon J.B., Zimmet P., Alberti K.G., Rubino F. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med J Br Diabet Assoc 2011, 28:628-642. International Diabetes Federation Taskforce on Epidemiology and Prevention. 10.1111/j.1464-5491.2011.03306.x.
61. Miras A.D., le Roux C.W. Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health. Lancet Diabetes Endocrinol 2014, 2:141-151. 10.1016/S2213-8587(13)70158-X.
62. Sjöström L., Peltonen M., Jacobson P., Sjöström C.D., Karason K., Wedel H., et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012, 307:56-65. 10.1001/jama.2011.1914.
63. Liou A.P., Paziuk M., Luevano J.-M., Machineni S., Turnbaugh P.J., Kaplan L.M. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013, 5:178ra41. 10.1126/scitranslmed.3005687.
64. Ryan K.K., Tremaroli V., Clemmensen C., Kovatcheva-Datchary P., Myronovych A., Karns R., et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014, 509:183-188. 10.1038/nature13135.
65. Tremaroli V., Karlsson F., Werling M., Ståhlman M., Kovatcheva-Datchary P., Olbers T., et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab 2015, 22:228-238. 10.1016/j.cmet.2015.07.009.
66. Aron-Wisnewsky J., Dore J., Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol 2012, 9:590.
67. Madsbad S., Dirksen C., Holst J.J. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol 2014, 2:152-164. 10.1016/S2213-8587(13)70218-3.
68. Kong L.-C., Tap J., Aron-Wisnewsky J., Pelloux V., Basdevant A., Bouillot J.-L., et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 2013, 98:16-24. 10.3945/ajcn.113.058743.
69. Damms-Machado A., Mitra S., Schollenberger A.E., Kramer K.M., Meile T., Königsrainer A., et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int 2015, 2015:e806248. 10.1155/2015/806248.
70. Graessler J., Qin Y., Zhong H., Zhang J., Licinio J., Wong M.-L., et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2013, 13:514-522. 10.1038/tpj.2012.43.
71. Ward E.K., Schuster D.P., Stowers K.H., Royse A.K., Ir D., Robertson C.E., et al. The Effect of PPI Use on Human Gut Microbiota and Weight Loss in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass. Obes Surg 2014, 10.1007/s11695-014-1275-1.
72. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009, 106:2365-2370. 10.1073/pnas.0812600106.
73. Verger E.O., Aron-Wisnewsky J., Dao M.C., Kayser B.D., Oppert J.-M., Bouillot J.-L., et al. Micronutrient and protein deficiencies after gastric bypass and sleeve gastrectomy: a 1-year follow-up. Obes Surg 2015, 10.1007/s11695-015-1803-7.
74. Shin N.-R., Lee J.-C., Lee H.-Y., Kim M.-S., Whon T.W., Lee M.-S., et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014, 63:727-735. 10.1136/gutjnl-2012-303839.
75. Tilg H., Moschen A.R. Microbiota and diabetes: an evolving relationship. Gut 2014, 63:1513-1521. 10.1136/gutjnl-2014-306928.
76. Ahima R.S., Lazar M.A. Physiology. The health risk of obesity-better metrics imperative. Science 2013, 341:856-858. 10.1126/science.1241244.
77. Beebe K., Sampey B., Watkins S.M., Milburn M., Eckhart A.D. Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. Clin Transl Sci 2014, 7:74-81. 10.1111/cts.12131.
78. Kussmann M., Morine M.J., Hager J., Sonderegger B., Kaput J. Perspective: a systems approach to diabetes research. Front Genet 2013, 4:205. 10.3389/fgene.2013.00205.
79. Heinken A., Thiele I. Systems biology of host-microbe metabolomics. Wiley Interdiscip Rev Syst Biol Med 2015, 7:195-219. 10.1002/wsbm.1301.
80. Shoaie S., Ghaffari P., Kovatcheva-Datchary P., Mardinoglu A., Sen P., Pujos-Guillot E., et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab 2015, 22:320-331. 10.1016/j.cmet.2015.07.001.